PARP1 and breast cancer: Based on previous evidence showing a critical role for PARP-1 in BC progression through the regulation of oxidative DNA damage and the resistance to pharmacological treatments [50, 51], we aimed to explore the potential clinical significance of PARP-1 in BC patients using the METABRIC database.